Literature DB >> 17252206

In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.

Donatella Paolino1, Rita Muzzalupo, Antonio Ricciardi, Christian Celia, Nevio Picci, Massimo Fresta.   

Abstract

A novel niosome formulation is proposed for topical drug delivery of ammonium glycyrrhizinate, a natural compound with an efficacious anti-inflammatory activity. Niosomes were made up of a new non ionic surfactant, alpha,omega-hexadecyl-bis-(1-aza-18-crown-6) (Bola-surfactant)-Span 80-cholesterol (2:3:1 molar ratio). Niosome vesicles were prepared with the thin layer evaporation method and were physico-chemically characterized. The tolerability of Bola-surfactant both as free molecules or assembled ion niosome vesicles was evaluated in vitro on cultured of human keratinocyte cells (NCTC2544). Human tolerability was evaluated on volunteers. The ability of Bola-niosomes to promote intracellular delivery was evaluated by confocal laser scanning microscopy (CLSM) studies. Human stratum corneum and epidermis (SCE) membranes were used in vitro to investigate the percutaneous permeation. The anti-inflammatory activity of ammonium glycyrrhizinate was evaluated in vivo on human volunteers with a chemically induced erythema. Experimental data show that Bola-niosomes are characterized by a mean size of approximately 400 nm and are able to provide an encapsulation efficiency of 40% with respect to the drug amount used during preparation. CLSM showed that Bola-niosomes were able to promote the intracellular uptake of the delivered substances. Bola-niosomes were also able to significantly improve (p<0.001) the percutaneous permeation of ammonium glycyrrhizinate with respect to both the aqueous drug solution and a physical mixture between unloaded Bola-niosomes and the aqueous drug solution. Bola-niosomes showed a suitable tolerability both in vitro and in vivo. Ammonium glycyrrhizinate-loaded Bola-niosomes determined a significant (p<0.001) and noticeable improvement of the in vivo anti-inflammatory activity of the drug. An effective example of conjugating innovative colloidal carriers, coming from pharmaceutical nanotechnology, and therapeutically effective natural compounds, coming from traditional medicine, was reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252206     DOI: 10.1007/s10544-007-9046-6

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  5 in total

1.  Dicationic alkylammonium bromide gemini surfactants. Membrane perturbation and skin irritation.

Authors:  João A S Almeida; Henrique Faneca; Rui A Carvalho; Eduardo F Marques; Alberto A C C Pais
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

Review 2.  Dermal and Transdermal Drug Delivery through Vesicles and Particles: Preparation and Applications.

Authors:  Unnati Garg; Karuna Jain
Journal:  Adv Pharm Bull       Date:  2021-02-06

3.  Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models.

Authors:  Carlotta Marianecci; Federica Rinaldi; Luisa Di Marzio; Marica Mastriota; Stefano Pieretti; Christian Celia; Donatella Paolino; Michelangelo Iannone; Massimo Fresta; Maria Carafa
Journal:  Int J Nanomedicine       Date:  2014-01-24

Review 4.  Synthesis and Potential Applications of Lipid Nanoparticles in Medicine.

Authors:  Ewelina Musielak; Agnieszka Feliczak-Guzik; Izabela Nowak
Journal:  Materials (Basel)       Date:  2022-01-17       Impact factor: 3.623

5.  Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice.

Authors:  Wandee Rungseevijitprapa; Panikchar Wichayapreechar; Bhagavathi Sundaram Sivamaruthi; Damrongsak Jinarat; Chaiyavat Chaiyasut
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.